Literature DB >> 24090052

Short Communication: Defining optimality of a test for recent infection for HIV incidence surveillance.

Reshma Kassanjee1, Thomas A McWalter, Alex Welte.   

Abstract

The estimation of HIV incidence from cross-sectional surveys using tests for recent infection has attracted much interest. It is increasingly recognized that the lack of high performance recent infection tests is hindering the implementation of this surveillance approach. With growing funding opportunities, test developers are currently trying to fill this gap. However, there is a lack of consensus and clear guidance for developers on the evaluation and optimization of candidate tests. A fundamental shift from conventional thinking about test performance is needed: away from metrics relevant in typical public health settings where the detection of a condition in individuals is of primary interest (sensitivity, specificity, and predictive values) and toward metrics that are appropriate when estimating a population-level parameter such as incidence (accuracy and precision). The inappropriate use of individual-level diagnostics performance measures could lead to spurious assessments and suboptimal designs of tests for incidence estimation. In some contexts, such as population-level application to HIV incidence, bias of estimates is essentially negligible, and all that remains is the maximization of precision. The maximization of the precision of incidence estimates provides a completely general criterion for test developers to assess and optimize test designs. Summarizing the test dynamics into the properties relevant for incidence estimation, high precision estimates are obtained when (1) the mean duration of recent infection is large, and (2) the false-recent rate is small. The optimal trade-off between these two test properties will produce the highest precision, and therefore the most epidemiologically useful incidence estimates.

Entities:  

Mesh:

Year:  2013        PMID: 24090052      PMCID: PMC3887426          DOI: 10.1089/aid.2013.0113

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  21 in total

1.  Improved HIV-1 incidence estimates using the BED capture enzyme immunoassay.

Authors:  John W Hargrove; Jean H Humphrey; Kuda Mutasa; Bharat S Parekh; J Steve McDougal; Robert Ntozini; Henry Chidawanyika; Lawrence H Moulton; Brian Ward; Kusum Nathoo; Peter J Iliff; Ekkehard Kopp
Journal:  AIDS       Date:  2008-02-19       Impact factor: 4.177

2.  Relating recent infection prevalence to incidence with a sub-population of assay non-progressors.

Authors:  Thomas Andrew McWalter; Alex Welte
Journal:  J Math Biol       Date:  2009-07-25       Impact factor: 2.259

Review 3.  Accuracy of serological assays for detection of recent infection with HIV and estimation of population incidence: a systematic review.

Authors:  Rebecca Guy; Judy Gold; Jesus M García Calleja; Andrea A Kim; Bharat Parekh; Michael Busch; Thomas Rehle; John Hargrove; Robert S Remis; John M Kaldor
Journal:  Lancet Infect Dis       Date:  2009-12       Impact factor: 25.071

4.  Comparison of HIV type 1 incidence observed during longitudinal follow-up with incidence estimated by cross-sectional analysis using the BED capture enzyme immunoassay.

Authors:  J Steven McDougal; Bharat S Parekh; Michael L Peterson; Bernard M Branson; Trudy Dobbs; Marta Ackers; Marc Gurwith
Journal:  AIDS Res Hum Retroviruses       Date:  2006-10       Impact factor: 2.205

5.  Quantitative detection of increasing HIV type 1 antibodies after seroconversion: a simple assay for detecting recent HIV infection and estimating incidence.

Authors:  Bharat S Parekh; M Susan Kennedy; Trudy Dobbs; Chou-Pong Pau; Robert Byers; Timothy Green; Dale J Hu; Suphak Vanichseni; Nancy L Young; Kachit Choopanya; Timothy D Mastro; J Steven McDougal
Journal:  AIDS Res Hum Retroviruses       Date:  2002-03-01       Impact factor: 2.205

6.  Do tests devised to detect recent HIV-1 infection provide reliable estimates of incidence in Africa?

Authors:  Charlotte Sakarovitch; Francois Rouet; Gary Murphy; Albert K Minga; Ahmadou Alioum; Francois Dabis; Dominique Costagliola; Roger Salamon; John V Parry; Francis Barin
Journal:  J Acquir Immune Defic Syndr       Date:  2007-05-01       Impact factor: 3.731

Review 7.  Principles and uses of HIV incidence estimation from recent infection testing--a review.

Authors:  S Le Vu; J Pillonel; Caroline Semaille; P Bernillon; Y Le Strat; L Meyer; J C Desenclos
Journal:  Euro Surveill       Date:  2008-09-04

Review 8.  Assays for the detection of recent infections with human immunodeficiency virus type 1.

Authors:  G Murphy; J V Parry
Journal:  Euro Surveill       Date:  2008-09-04

9.  Investigating the utility of the HIV-1 BED capture enzyme immunoassay using cross-sectional and longitudinal seroconverter specimens from Africa.

Authors:  Etienne Karita; Matt Price; Eric Hunter; Elwyn Chomba; Susan Allen; Lin Fei; Anatoli Kamali; Eduard J Sanders; Omu Anzala; Michael Katende; Nzeera Ketter
Journal:  AIDS       Date:  2007-02-19       Impact factor: 4.177

10.  Effect of natural and ARV-induced viral suppression and viral breakthrough on anti-HIV antibody proportion and avidity in patients with HIV-1 subtype B infection.

Authors:  Sarah K Wendel; Caroline E Mullis; Susan H Eshleman; Joel N Blankson; Richard D Moore; Jeanne C Keruly; Ron Brookmeyer; Thomas C Quinn; Oliver Laeyendecker
Journal:  PLoS One       Date:  2013-02-20       Impact factor: 3.240

View more
  17 in total

1.  Validation of the Limiting Antigen Avidity Assay to Estimate Level and Trends in HIV Incidence in an A/D Epidemic in Rakai, Uganda.

Authors:  Oliver Laeyendecker; Ronald H Gray; M Kate Grabowski; Steven J Reynolds; Anthony Ndyanabo; Joseph Ssekasanvu; Reinaldo E Fernandez; Maria J Wawer; David Serwadda; Thomas C Quinn
Journal:  AIDS Res Hum Retroviruses       Date:  2019-01-29       Impact factor: 2.205

2.  Assessment of ambiguous base calls in HIV-1 pol population sequences as a biomarker for identification of recent infections in HIV-1 incidence studies.

Authors:  Karolin Meixenberger; Andrea Hauser; Klaus Jansen; Kaveh Pouran Yousef; Stefan Fiedler; Max von Kleist; Stephen Norley; Sybille Somogyi; Osamah Hamouda; Norbert Bannert; Barbara Bartmeyer; Claudia Kücherer
Journal:  J Clin Microbiol       Date:  2014-06-11       Impact factor: 5.948

3.  Comparison of antibody responses to HIV infection in Ugandan women infected with HIV subtypes A and D.

Authors:  Andrew F Longosz; Charles S Morrison; Pai-Lien Chen; Hilmarie H Brand; Eric Arts; Immaculate Nankya; Robert A Salata; Thomas C Quinn; Susan H Eshleman; Oliver Laeyendecker
Journal:  AIDS Res Hum Retroviruses       Date:  2014-11-19       Impact factor: 2.205

4.  Infection Staging and Incidence Surveillance Applications of High Dynamic Range Diagnostic Immuno-Assay Platforms.

Authors:  Eduard Grebe; Alex Welte; Jake Hall; Sheila M Keating; Shelley N Facente; Kara Marson; Jeffrey N Martin; Susan J Little; Matthew A Price; Esper G Kallas; Michael P Busch; Christopher D Pilcher; Gary Murphy
Journal:  J Acquir Immune Defic Syndr       Date:  2017-12-15       Impact factor: 3.731

5.  Development and Evaluation of a Modified Fourth-Generation Human Immunodeficiency Virus Enzyme Immunoassay for Cross-Sectional Incidence Estimation in Clade B Populations.

Authors:  Allison R Kirkpatrick; Eshan U Patel; Connie L Celum; Richard D Moore; Joel N Blankson; Shruti H Mehta; Gregory D Kirk; Joseph B Margolick; Thomas C Quinn; Susan H Eshleman; Oliver Laeyendecker
Journal:  AIDS Res Hum Retroviruses       Date:  2016-05-05       Impact factor: 2.205

Review 6.  How can we better identify early HIV infections?

Authors:  Nora E Rosenberg; Christopher D Pilcher; Michael P Busch; Myron S Cohen
Journal:  Curr Opin HIV AIDS       Date:  2015-01       Impact factor: 4.283

7.  Viral load criteria and threshold optimization to improve HIV incidence assay characteristics.

Authors:  Reshma Kassanjee; Christopher D Pilcher; Michael P Busch; Gary Murphy; Shelley N Facente; Sheila M Keating; Elaine Mckinney; Kara Marson; Matthew A Price; Jeffrey N Martin; Susan J Little; Frederick M Hecht; Esper G Kallas; Alex Welte
Journal:  AIDS       Date:  2016-09-24       Impact factor: 4.177

8.  Computational analysis of antibody dynamics identifies recent HIV-1 infection.

Authors:  Kelly E Seaton; Nathan A Vandergrift; Aaron W Deal; Wes Rountree; John Bainbridge; Eduard Grebe; David A Anderson; Sheetal Sawant; Xiaoying Shen; Nicole L Yates; Thomas N Denny; Hua-Xin Liao; Barton F Haynes; Merlin L Robb; Neil Parkin; Breno R Santos; Nigel Garrett; Matthew A Price; Denise Naniche; Ann C Duerr; Sheila Keating; Dylan Hampton; Shelley Facente; Kara Marson; Alex Welte; Christopher D Pilcher; Myron S Cohen; Georgia D Tomaras
Journal:  JCI Insight       Date:  2017-12-21

9.  Use of Hepatitis C Virus (HCV) Immunoglobulin G Antibody Avidity as a Biomarker to Estimate the Population-Level Incidence of HCV Infection.

Authors:  Eshan U Patel; Andrea L Cox; Shruti H Mehta; Denali Boon; Caroline E Mullis; Jacquie Astemborski; William O Osburn; Jeffrey Quinn; Andrew D Redd; Gregory D Kirk; David L Thomas; Thomas C Quinn; Oliver Laeyendecker
Journal:  J Infect Dis       Date:  2016-01-14       Impact factor: 5.226

10.  Antibody avidity-based approach to estimate population-level incidence of hepatitis C.

Authors:  Denali Boon; Veronica Bruce; Eshan U Patel; Jeffrey Quinn; Aylur K Srikrishnan; Saravanan Shanmugam; Syed Iqbal; Pachamuthu Balakrishnan; Matthew Sievers; Gregory D Kirk; David L Thomas; Thomas C Quinn; Andrea L Cox; Kimberly A Page; Sunil S Solomon; Shruti H Mehta; Oliver Laeyendecker
Journal:  J Hepatol       Date:  2020-03-30       Impact factor: 30.083

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.